Skip to content
Plozalizumab
Plozalizumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against C-C chemokine receptor type 2.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
6 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diabetic nephropathiesD003928EFO_000040111
Multiple sclerosisD009103EFO_0003885G3511
NeoplasmsD009369C8011
AtherosclerosisD050197EFO_0003914I25.111
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePLOZALIZUMAB
INNplozalizumab
Description
Plozalizumab (INN; hu1D9) is a humanized monoclonal antibody designed for the treatment of diabetic nephropathy and arteriovenous graft patency.
Classification
Antibody
Drug classmonoclonal antibodies
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID1610761-46-0
RxCUI
ChEMBL IDCHEMBL3707228
ChEBI ID
PubChem CID
DrugBankDB12520
UNII ID4XG66BMN0D (ChemIDplus, GSRS)
Target
Agency Approved
CCR2
CCR2
Organism
Homo sapiens
Gene name
CCR2
Gene synonyms
CMKBR2
NCBI Gene ID
Protein name
C-C chemokine receptor type 2
Protein synonyms
CD192, chemokine (C-C motif) receptor 2, MCP-1 receptor, MCP-1-R, Monocyte chemoattractant protein 1 receptor, monocyte chemotactic protein 1 receptor
Uniprot ID
Mouse ortholog
Ccr2 (12772)
C-C chemokine receptor type 2 (Q61172)
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 29 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details